openPR Logo
Press release

Germany IBD Therapeutics Market will experience a noticeable growth during the forecast period 2019-2025

03-13-2020 10:53 AM CET | Health & Medicine

Press release from: Orion Market Research

Germany IBD Therapeutics Market

Germany IBD Therapeutics Market

Germany IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.4% during the forecast period. The growing IBD patient population in the region is one of the major driving forces for the growth of the market in the country. According to the national institutes of health, the prevalence of Crohn's disease in Germany was estimated to be 322 per 100,000 in Germany in 2018. Moreover, the growing demand for quality healthcare services in the region is another factor boosting the germany IBD market.

Request a Free Sample of our Report on Germany IBD Therapeutics Market:

The healthcare expenditure in Germany has also been increasing significantly in the past years. A similar trend is expected to be followed in the future. This is expected to be one of the key reasons which are estimated to increase the inflow of R&D funds in inflammatory diseases such as IBD in the future. This is projected to create opportunities for the development of the market over the forecast period.

Germany IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. For Crohn's and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases.

This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

A Full Report of Germany IBD Therapeutics Market is Available at

Germany IBD Therapeutics Market

By Disease Type
o Ulcerative Colitis
o Crohn's Disease

By Treatment Type
o Surgery
o Anti- Inflammatory Drug Administration
o Steroids
o Immunosuppressant
o Biological Drugs
o Amino salicylates
o Others

Company Profiles
o AbbVie Inc.
o Allergan, PLC
o Boehringer Ingelheim International GmbH
o Daiichi Sankyo Co. Ltd.
o Eli Lilly and Co.
o Johnson & Johnson Services Inc.
o Mercator Pharmaceutical Solutions
o Pfizer Inc.
o RPG Life Sciences Ltd.
o Sanofi S.A.
o Takeda Pharmaceutical Co., Ltd.

For More Customized Data, Request for Report Customization @

For More Information, Visit

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Germany IBD Therapeutics Market will experience a noticeable growth during the forecast period 2019-2025 here

News-ID: 1966187 • Views: 172

More Releases from Orion Market Research

US 3D Scanning Market to Witness Growth Acceleration by 2028
The US companies contribute a significant market share in the 3D scanning market. The companies, which will share a momentous market share, are 3D Digital Corporation, 3D Systems Inc. Autodesk Inc. and so on. Additionally, more accurate and precise 3D scanners are available in the market of the US, and hence along with the high number of unit sells, it is estimated that the average cost of the scanner will
Unmanned Surface Vehicle (USV) Market Booming Worldwide with Latest Trend and Fu …
The global unmanned surface vehicle (USV) market is estimated to grow at a CAGR of nearly 14.0% during the forecast period. A significant rise in defense contracts for the development of unmanned surface vehicles is offering an opportunity for the growth of the market. The Navy has an increasing interest in USVs for maritime operations. This allows to carry out a comprehensive range of tasks, including intelligence surveillance and reconnaissance
Global Smart Indoor Garden Systems Market Worldwide Industry Analysis, Future De …
The global smart indoor garden systems market is anticipated to grow at a considerable CAGR of 8.1% during the forecast period. The smart indoor gardening system features technology that allows users to grow fresh herbs, vegetables, fruits, as well as flowers in a closed environment with high nutrition without using plant hormones, pesticides, and other harmful substances. Smart indoor gardening systems are compact and have several features such as smart
Global Online Reading Platform Market Competitive Landscape, Growth Factors, Rev …
The global online reading platform market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period. One of the core factors that is fueling the market growth includes the high smartphone and tablet penetration across the globe. Over the past few years, the smartphone and tablet market witnessed exponential sales growth due to an easy excess of internet which enhanced the availability of e-books for most

All 5 Releases

More Releases for IBD

Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per
Indian IBD Therapeutics Market Growth, Opportunity, Size, Share and Forecast 201 …
Indian IBD therapeutics market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The Indian pharmaceutical industry has been consistently growing with the public and private investments, making India as a potential market for the treatment of prevailing diseases such as IBD. Additionally, healthcare expenditure is playing a critical role in fueling the IBD therapeutics market in India. Request a Free Sample of our
Canada IBD Therapeutics Market, Industry Trends, Size, Competitive Analysis and …
Canada IBD Therapeutics market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,
Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit a Steady 2.6% CAG …
Competition is expected to remain high from 2017 to 2025 in the global inflammatory bowel disease (IBD) treatment market. During this time, the market will witness a slew of launches as manufacturers invest in the development of novel therapeutics. According to a new study by Transparency Market Research (TMR), a paradigm shift toward biosimilar and biologic drugs is expected, which will offer a fresh burst of opportunities to the global
Global Inflammatory Bowel Disease (IBD) Treatment Market to Grow at 2.6% CAGR th …
A new thorough study titled “Inflammatory Bowel Disease (IBD) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has recently been submitted to the database of Market Research Reports Search Engine (MRRSE). The global inflammatory bowel disease treatment market is projected to grow at 2.6% CAGR through 2025. In terms of revenue, the market is anticipated to reach nearly US$ 15 Bn in revenues. Request Sample Copy